Omega Healthcare Investors, Inc. (OHI)
| Market Cap | 14.68B +18.4% |
| Revenue (ttm) | 1.26B +13.2% |
| Net Income | 841.99M +82.4% |
| EPS | 2.80 +73.7% |
| Shares Out | 316.92M |
| PE Ratio | 16.51 |
| Forward PE | 24.98 |
| Dividend | $2.72 (5.88%) |
| Ex-Dividend Date | Aug 3, 2026 |
| Volume | 522,368 |
| Open | 46.86 |
| Previous Close | 46.97 |
| Day's Range | 45.99 - 46.86 |
| 52-Week Range | 39.26 - 52.39 |
| Beta | 0.58 |
| Analysts | Buy |
| Price Target | 51.94 (+12.11%) |
| Earnings Date | Jul 29, 2026 |
About OHI
Omega Healthcare Investors, Inc. is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK and Canada. Omega Healthcare Investors, Inc. is based in Hunt Valley, United States. The firm is incorporated in Maryland.
Financial Performance
In 2025, OHI's revenue was $1.19 billion, an increase of 13.19% compared to the previous year's $1.05 billion. Earnings were $572.03 million, an increase of 40.78%.
Financial StatementsAnalyst Summary
According to 20 analysts, the average rating for OHI stock is "Buy." The 12-month stock price target is $51.94, which is an increase of 12.11% from the latest price.
News
Omega Healthcare price target raised to $58 from $52 at Citi
Citi analyst Nick Joseph raised the firm’s price target on Omega Healthcare (OHI) to $58 from $52 and keeps a Buy rating on the shares.
Omega Healthcare price target raised to $56 from $52 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Omega Healthcare (OHI) to $56 from $52 and keeps an Overweight rating on the shares. Healthcare REIT results highlight strong Senior Housing…
Omega Healthcare Investors Earnings Call Transcript: Q2 2026
Q2 2026 saw strong revenue and net income growth, driven by asset sales and new investments, with leverage at historic lows and a raised AFFO guidance. Portfolio management remains proactive, with no major operator concerns and a robust pipeline in senior housing and U.K. care homes.
Omega Healthcare Investors Earnings release: Q2 2026
Omega Healthcare Investors released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Omega Healthcare Investors Quarterly report: Q2 2026
Omega Healthcare Investors has published its Q2 2026 quarterly earnings report on July 30, 2026.
Omega Reports Second Quarter 2026 Results and Recent Developments
HUNT VALLEY, Md.--(BUSINESS WIRE)---- $OHI #Healthcare--Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended June 30, 2026. SECOND ...
Omega Healthcare raises quarterly dividend to 68 per share from 67c
Omega Healthcare (OHI) Investors announced that the company’s Board of Directors declared a cash dividend of 68c per share, increasing the quarterly dividend on its common stock by 1c per…
Omega Announces Increase in Quarterly Dividend
HUNT VALLEY, Md.--(BUSINESS WIRE)---- $OHI #Healthcare--Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company's Board of Directors declared a cash dividend of $0.68 per share, i...
Omega Healthcare initiated with an Underweight at Barclays
Barclays initiated coverage of Omega Healthcare (OHI) with an Underweight rating and $51 price target While initiating coverage of six healthcare REITs, the analyst tells investors that healthcare rea...
Omega Announces Second Quarter Earnings Release Date and Conference Call
HUNT VALLEY, Md.--(BUSINESS WIRE)---- $OHI #Healthcare--Omega Healthcare Investors, Inc. (NYSE:OHI) announced today that it is scheduled to release its earnings results for the quarter ended June 30, ...
Omega Healthcare price target lowered to $47 from $50 at Scotiabank
Scotiabank lowered the firm’s price target on Omega Healthcare (OHI) to $47 from $50 and keeps a Sector Perform rating on the shares. The firm sees real estate investment trust…
Omega Healthcare resumed with an Outperform at Raymond James
Raymond James resumed coverage of Omega Healthcare (OHI) with an Outperform rating and $50 price target The underlying tenant credit profile continues to improve post the completed CommuniCare and pen...
Omega Healthcare price target lowered to $46 from $48 at Truist
Truist lowered the firm’s price target on Omega Healthcare (OHI) to $46 from $48 and keeps a Hold rating on the shares. The firm is updating its model with incorporated…
Omega Healthcare Investors Transcript: AGM 2026
The meeting saw all board nominees elected, auditor ratified, and executive compensation approved. Management discussed the strategic sale of Communicare assets and addressed dividend policy, noting ongoing board review but no set timeline for increases.
Omega Healthcare Investors Slides: Investor presentation
Omega Healthcare Investors has posted slides in relation to its latest quarterly earnings report, which was published on May 29, 2026.
Omega Healthcare price target raised to $49 from $46 at BofA
BofA raised the firm’s price target on Omega Healthcare (OHI) to $49 from $46 and keeps an Underperform rating on the shares. The firm updated its price targets on a…
Omega Healthcare announces retirement of CEO Pickett
The company states: “Omega Healthcare (OHI) announced that Matthew Gourmand, President of Omega, will become the Company’s Chief Executive Officer in conjunction with the planned retirement of Taylor ...
Omega Announces Its Planned Leadership Transition
HUNT VALLEY, Md.--(BUSINESS WIRE)---- $OHI #Healthcare--Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) today announced that Matthew Gourmand, President of Omega, will become t...
Omega Healthcare price target raised to $50 from $48 at Scotiabank
Scotiabank analyst Nicholas Yulico raised the firm’s price target on Omega Healthcare (OHI) to $50 from $48 and keeps a Sector Perform rating on the shares. The firm is updating…
Omega Healthcare Investors Proxy statement: Proxy filing
Omega Healthcare Investors filed a proxy statement on May 21, 2026, providing details for shareholder voting and corporate governance matters.
Omega Healthcare price target raised to $54 from $52 at UBS
UBS raised the firm’s price target on Omega Healthcare (OHI) to $54 from $52 and keeps a Buy rating on the shares.
Omega Healthcare price target raised to $52 from $50 at BMO Capital
BMO Capital raised the firm’s price target on Omega Healthcare (OHI) to $52 from $50 and keeps a Market Perform rating on the shares as part of a broader research…
Omega Healthcare price target raised to $48 from $47 at RBC Capital
RBC Capital raised the firm’s price target on Omega Healthcare (OHI) to $48 from $47 and keeps a Sector Perform rating on the shares. The company delivered a healthy earnings…
Omega Healthcare price target raised to $52 from $50 at Citi
Citi analyst Nick Joseph raised the firm’s price target on Omega Healthcare (OHI) to $52 from $50 and keeps a Buy rating on the shares.
Omega Healthcare Investors Earnings Call Transcript: Q1 2026
Q1 2026 saw strong AFFO and FAD growth, driven by acquisitions and active portfolio management, with a robust investment pipeline and competitive market conditions. Asset sales and redeployment are expected to further boost earnings, while guidance was raised for the year.